Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles

Gynecological Endocrinology

Volumn 23, Issue 6, 2007, Pages 338-342

  Seow, Kok Min ^a,b,c   Lin, Yu Hung ^a,c   Huang, Lee Win ^a,d   Hsieh, Bih Chwen ^a,c   Huang, Shih Chia ^a   Chen, Chin Yu ^a   Chen, Pei Hsin ^a   Tzeng, Chii Ruey ^d   Hwang, Jiann Loong ^a,d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cetrorelix; Luteinizing hormone; Pregnancy outcome; Progesterone rise

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADULT; CLOMIPHENE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; MENOTROPINS; OVULATION INDUCTION; PROGESTERONE; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 34447128667     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701403629     Document Type: Article

References (22)

1. Feldberg D, Goldman GA, Ashkenazi J, Dicker D, Shelef M, Goldman JA. The impact of high progesterone levels in the follicular phase of in vitro fertilization (IVF) cycles: a comparative study. J In Vitro Fert Embryo Transf 1989;6: 11-14.
2. Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ. Progesterone levels on the day of human chorionic gonadotropins administration in cycles with gonadotropins-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990;54:853-857.
3. Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803.
4. Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090-1094.
5. Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotrophin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011-1017.
6. Harada T, Yoshida S, Katagiri C, Takao N, Ikenari T, Toda T, Mio Y, Terakawa N. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod 1995;10:1060-1064.
7. Ubaldi F, Smitz J, Wisanto A, Joris H, Schietecatte J, Van Steirteghem A, Devroey P. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod 1995;12:3091-3096.
8. Olivennes F, Cunha-Filho JS, Fanchin R, Bouchard P, Frydman R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 2002;8:279-290.
9. Smacklon N, Fauser BC. Regulation of follicle development and novel approaches to ovarian stimulation for IVF. Hum Reprod Update 2000;6:307-312.
10. de Jong D, Macklon NS, Fauser BC. A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the 'follicle-stimulating hormone window' combined with the gonadotropins-releasing hormone antagonist cetrorelix. Fertil Steril 2000;73:1051-1054.
11. Leroy I, d'Acremont M, Brailly-Tabard S, Frydman R, de Mouzon J, Bouchard P. A single injection of a gonadotropins-releasing hormone (GnRH) antagonist (cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge. Fertil Steril 1994;62:461-467.
12. Hwang JL, Huang LW, Hsieh BC, Tsai YL, Huang SC, Chen CY, Hsieh ML, Chen PH, Lin YH. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles. Hum Reprod 2003;18:45-49.
13. Felberbaum RE, Alano C, Ludwig M, Riethmüller-Winzen H, Grigat M, Devroey P, Diedrich K. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 2000;15:1015-1020.
14. Ubaldi F, Albano C, Peukert M, Riethmüller-Winzen H, Camus M, Smitz J, Van Steirteghem A, Devroey P. Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod 1996;11:1405-1407.
15. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohi J, Pellicer A. Premature luteinization during gonadotropins-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444-1449.
16. Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G, Ferrari A. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 1999;14:601-605.
17. Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action - a hypothesis revisited. Fertil Steril 1984;42:331-344.
18. Kerin JF, Liu JH, Phillipou G, Yen SSC. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab 1985;61:265-268.
19. Jennings JC, Moreland K, Peterson M. In vitro fertilization: a review of drug therapy and clinical management. Drugs 1996;52:313-343.
20. Martikainen H, Rönnberg L, Ruokonen A, Kauppila A. Gonadotropin pulsatility in a stimulated cycle: clomiphene citrate increases pulse amplitudes of both luteinizing hormone and follicle-stimulating hormone. Fertil Steril 1991;56:641-645.
21. Christin-Maitre S, Olivennes F, Dubourdieu S, Chabbert-Buffet N, Charbonnel B, Frydman R, Bouchard P. Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation. Clin Endocrinol (Oxf) 2000;52:721-726.
22. Copperman AB, Horowitz GM, Kaplan P, Scott RT, Navot D, Hofmann GE. Relationship between circulating human chorionic gonadotropins levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil Steril 1995;63:1267-1271.